
Journal of Medicinal Chemistry p. 1600 - 1607 (1995)
Update date:2022-08-05
Topics:
Clader, John W.
Berger, Joel G.
Burrier, Robert E.
Davis, Harry R.
Domalski, Martin
et al.
Substituted (1,2-diarylethyl)amides have been prepared and evaluated for their ability to inhibit microsomal acyl-CoA:cholesterol acyltransferase activity in vitro and to lower hepatic cholesteryl ester content in vivo in a cholesterol-fed hamster.Simple unsubstituted (diarylethyl)amides were potent inhibitors in vitro but showed poor activity in vivo.Introduction of polar groups at specific locations on the diarylethylamine moiety decreased in vitro activity but increased in vivo activity.Both effects were highly structure dependent, suggesting specific interactions which were mediating activity in each model.Optimization of these opposing effects led to compounds which were potent in both models.
View MoreShanghai KFSL Pharmaceutical Technology Co.,Ltd.
Contact:+86-21-39971718
Address:859 jiadingchengliu shanghai
Contact:86-21-50966856
Address:Building 5,300 Chuanzhan Road,Pudong New District,Shanghai
Contact:+86-577-65618087-605
Address:Room 402, Unit 4 Xinhu Bldg. Waitan Ruian City, Zhejiang China.
LABTER PARMATECH(BEIJING)CO.,LTD
website:http://www.labter.com.cn/
Contact:+86-10-56330744
Address:NO.19,TIANRONG STREET,DAXING BIOMEDICIAL BASE ,ZHONGGUANCUN SCIENCE AND TECHNOLOGY PARK,BEIJING ,CHINA
Zhengzhou Minzhong Pharmaceutical Co.,ltd
Contact:0086-371-65797115
Address:15/F,Jiangshan Bldg, NO.126 Huanghe Road,Zhengzhou, China
Doi:10.1021/ja01511a045
(1959)Doi:10.1002/jhet.5570290636
(1992)Doi:10.1021/jo00119a010
(1995)Doi:10.1016/j.tetlet.2013.08.127
(2013)Doi:10.1039/c3ce40273h
(2013)Doi:10.1007/BF00866594
(1992)